1. South Korea Stocks

  2. •

    Process industries

  3. •

    Chemicals: specialty
T&L Co. Ltd.

T&L Co. Ltd.

KKRX:340570
24,400.00
KRW
-200.00
(-0.81%)
3,161.76EPS
8.79P/E
445.75BMarket Cap
Nov 12Next Earn
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
2,057.48
2,548.66
3,052.27
4,423.6
5,025.78
7,151.46
10,832.86
10,185.79
10,906.59
Basic EPS, GAAP
364
569.25
754.3
1,205
1,301
1,699.5
2,874.5
2,362.5
3,161.76
Free Cash Flow per Basic Share
279.73
277.66
443.55
184
-36.84
1,095.64
1,868
1,216.45
1,920.56
Dividend per Share
75.01
75
96.15
100.02
200.3
224.98
274.99
375.64
- -
Book Value per Share
1,685.54
2,056.39
4,426.14
5,541.91
6,570.38
8,024.84
10,619.18
12,545.65
13,983
Tangible Book Value per Share
1,608.99
1,994.8
4,342.07
5,434.84
6,464.63
7,832.04
10,393.41
12,312.24
13,741.78
Basic Weighted Avg Shares
13
13
13
16
16
16
16
16
16
Sales/Revenue/Turnover
26,331
32,623
40,633
71,896
81,577
115,461
174,892
164,158
175,160
Operating Margin (%)
20.03
23.68
23.61
31.06
29.8
26.71
32.57
28.24
33.9
Depreciation Expense
833
1,010
1,242
1,690
2,101
2,797
3,901
4,664
4,847
Net Income, GAAP
4,658
7,286
10,042
19,585
21,118
27,439
46,408
38,075
50,778
Effective Tax Rate (%)
9.24
12.99
12.49
16.42
17.38
17
25.49
20.38
22.11
Profit Margin (%)
17.69
22.34
24.71
27.24
25.89
23.76
26.54
23.19
28.99
Working Capital
6,743
9,434
41,302
45,411
49,080
60,796
90,650
110,899
132,461
LT Debt
3,351
2,708
18
131
67
47
300
156
84
Total Equity
27,238
33,231
71,951
90,089
106,072
129,553
171,436
201,160
224,207
Return on Invested Capital (%)
- -
19.46
15.26
22.45
19.84
21.14
26.95
19.03
21.38
Return on Capital (%)
- -
21.62
18.53
24.13
21.52
23.27
30.79
20.4
24.55
Return on Common Equity (%)
- -
24.1
19.09
24.17
21.53
23.29
30.84
20.44
24.59

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
162
153
166
LT Borrowings
- -
- -
- -
LT Finance Leases
156
120
84
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
16
16
16
Market Capitalization
393,240
400,456
445,752

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
126,087
147,460
160,678
Cash, Cash Equivalents & STI
90,553
97,639
102,439
Accounts Receivable, Net
16,710
30,115
30,478
Inventories
16,259
16,531
22,892
Total Current Liabilities
15,188
33,342
28,217
Payables & Accruals
- -
- -
- -
ST Debt
162
153
166
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
22.95%
17.34%
Free Cash Flow
- -
-638.47%
-34.99%
Net Income, GAAP
- -
36.79%
-17.96%
Sales/Revenue/Turnover
- -
35.46%
-6.14%
Total Cash Common Dividend
- -
39.46%
36.36%

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
24,814
54,837
48,724
46,517
174,892
2025
51,317
38,765
40,673
33,403
164,158
2026
45,067
56,017
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
440
1,073
809
541.64
2,874.5
2025
982
485
702.07
190.55
2,362.5
2026
1,025.38
1,244.5
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
274.99
2025
- -
- -
- -
- -
375.64
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Yoon-So Choi
Full Time Employees
237
Sector
Process industries
Industry
Chemicals: specialty
Address
767, Sinsu-ro Yongin-si GY South Korea 16827
IPO Date
Nov 20, 2020
Website
tnl.co.kr
Similar Companies
Petkim Petrokimya Holding Anonim Sirketi (BIST:PETKM)
Albemarle Corporation (NYSE:ALB)
Linde plc (NASDAQ:LIN)
Gubre Fabrikalari T.A.S. (BIST:GUBRF)
IOL Chemicals & Pharmaceuticals Ltd. (NSE:IOLCP)
Dow Inc. (NYSE:DOW)
Business
T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea, with operations focused on wound care, orthopedic fixation, polymer resins and additives, and related adhesive and structural materials. The company develops and markets hydrocolloid and foam wound care dressings, hydrogels, silicone and alginate-based solutions, as well as casts, splints, and other orthopedic fixation products; it also produces waterborne resins, hardeners, functional additives, and urethane foam for diverse industrial applications. T&L Co., Ltd. operates across domestic and international markets, supplying medical devices and polymer materials to healthcare providers, distributors, and manufacturers. Founding year and headquarters: founded 1998; headquartered in Yongin-si, Gyeonggi-do, South Korea. Primary business activity is the design, manufacturing, and distribution of medical wound care products, orthopedic fixation devices, and polymer chemical products, including related materials and solutions used in healthcare, industrial, and consumer applications. The company maintains a focused product portfolio that includes wound care dressings (hydrocolloid, foam, hydrogel, silicone, alginate), orthopedic casting and splinting systems, and a range of polymer-based chemical products (waterborne resins, hardeners, functional additives, urethane foam) for customers in Korea and overseas. Subsidiaries or relationships with parent groups are not publicly detailed, but the company positions itself as a vertically integrated supplier of both medical consumables and polymer materials.